The deal, which has an enterprise value of £3bn, is the first one by Cinven’s seventh fund
US buyout firm KKR has agreed to sell the life sciences company LGC Group to a consortium jointly led by private equity groups Cinven and Astorg.
The deal has an enterprise value of approximately £3bn, a personal familiar with the transaction told Private Equity News. KKR has made about three times its money since the acquisition of the company from Bridgepoint in 2015, the person said.
The private equity firms declined to comment on the financial terms of the transaction.
The investment is the first deal struck by Cinven’s seventh fund, closed in May after raising €10bn to invest in European buyouts and selective North American opportunities.
LGC, which provides measurement and testing solutions, reported a revenue of £448m in 2019, with organic revenue growth accelerating to 10% per annum since 2016. Under KKR’s ownership, the company made 15 acquisitions in the last five years.
London-based Cinven and Paris-based Astorg said they identified LGC as an attractive investment opportunity because of its “strong performance and organic growth” and they saw “significant future development opportunities”.
Established in 1842, LGC employs more than 3,200 people, is headquartered in the UK and serves almost 50,000 laboratories worldwide from its global office network spanning 22 countries across five continents.
“Cinven’s investment in LGC was identified as a result of the healthcare sector team’s focus on the life sciences space,” said Supraj Rajagopalan, partner at Cinven. “LGC is exposed to a wide range of diversified and fast-growing end markets across the Standards and Genomics sectors and we look forward to working with the highly experienced management team to continue investing in strengthening and broadening LGC’s global footprint and portfolio of leading, high-quality products.”
The deal is still subject to regulatory approvals.
Source: Private Equity News
Can’t stop reading? Read more
Permira joins race for The Team as sports agency attracts buyout interest
Permira joins race for The Team as sports agency attracts buyout interest Permira is among several investors exploring a potential acquisition of The Team, the sports talent agency formerly known as Wasserman, according to a report by the New York Times. The firm...
Australian investors embark on UK–France tour to deploy $430bn into Europe
Australian investors embark on UK–France tour to deploy $430bn into Europe Australian superannuation funds are ramping up their focus on European private markets, with senior investors travelling to France and the UK to source new opportunities across infrastructure...
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions
TA Associates eyes $810m takeover of UK-listed Advanced Medical Solutions TA Associates is in talks to acquire Advanced Medical Solutions in a potential $810m transaction, Reuters reported. The US-based private equity firm is preparing a possible offer of 280p per...